<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02888691</url>
  </required_header>
  <id_info>
    <org_study_id>HiLo12</org_study_id>
    <nct_id>NCT02888691</nct_id>
  </id_info>
  <brief_title>Low Carbohydrate Diet vs. High Carbohydrate Diet in Type 1 Diabetes</brief_title>
  <acronym>HiLo12</acronym>
  <official_title>Low Carbohydrate Diet vs. High Carbohydrate Diet in Type 1 Diabetes: A Randomized Crossover Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate glycemic control during a low carbohydrate diet
      compared with during a high carbohydrate diet in adults with insulin pump treated type 1
      diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time in euglycemia</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in time spent with glucose values 4.0-10.0 mmol/l assessed by continuous glucose monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean glucose</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in mean glucose value assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standard deviation of glucose</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in standard deviation of glucose values assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coefficient of variation of glucose</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in coefficient of variation of glucose values assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean amplitude of glycemic excursions</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in mean amplitude of glycemic excursions assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in hypoglycemia</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in time spent with glucose values ≤ 3.9 mmol/l assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in hyperglycemia</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in time spent with glucose values &gt; 10.0 mmol/l assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in A1c</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in hemoglobin A1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC low</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in area under the curve &lt;4.0 mmol/l assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC high</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in area under the curve &gt;10.0 mmol/l assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post breakfast glucose excursion</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in post breakfast glucose excursion assessed by continuous glucose monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe hypoglycemia</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in number of severe hypoglycemia episodes (glucagon or intravenous glucose administration)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total daily dose</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in total daily insulin dose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total daily basal insulin 24 hour</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in total daily basal insulin in the time range 00:00-24:00</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total nightime basal insulin</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in total nighttime basal insulin in the time range 00:00-06:00</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total daytime basal insulin</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in total daytime basal insulin in the time range 06:00-24:00</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total daily bolus insulin</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in total daily bolus insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose readings</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in number of blood glucose readings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carbohydrate servings</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in number of carbohydrate servings (one serving ≥ 15 grams)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in body composition assessed by Dual-energy X-ray Absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip circumference</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in hip circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in waist circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes treatment satisfaction</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in Diabetes Treatment Satisfaction Questionnaire score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemia fear</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in Hypoglycemia Fear Survey score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in total cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in HDL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in LDL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free fatty acids</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in free fatty acids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sodium</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in sodium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potassium</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in potassium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in creatinine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urate</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in urate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Albumin</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in albumin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in hemoglobin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leucocytes</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in leucocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thrombocytes</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in thrombocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iron</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in iron</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transferrin</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in transferrin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ferritin</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in ferritin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Folate</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in folate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin B-12</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in vitamin B-12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Magnesium</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in magnesium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zinc</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in zinc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>U-alb-crea ratio</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in urine albumin-creatinine ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Supar</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in Supar</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in CRP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-1</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in IL-1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-6</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in IL-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-8</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in IL-8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TNF-alpha</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Difference in change in TNF-alpha</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Carbohydrate intake</measure>
    <time_frame>From baseline to 12 weeks</time_frame>
    <description>Daily carbohydrate intake assessed by insulin pump download</description>
  </other_outcome>
  <other_outcome>
    <measure>Ketones</measure>
    <time_frame>Spot test at week 0, 2, 4, 6, 8, 10 and 12</time_frame>
    <description>Morning blood ketone values</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Low Carbohydrate Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>&lt; 100 grams of carbohydrate per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Carbohydrate Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>&gt; 250 grams of carbohydrate per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low carbohydrate diet</intervention_name>
    <arm_group_label>Low Carbohydrate Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High carbohydrate diet</intervention_name>
    <arm_group_label>High Carbohydrate Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 diabetes ≥3 years

          -  Insulin pump use ≥1 year

          -  HbA1c ≥53 mmol/mol (7.0%)

          -  BMI 20-27 kg/m2

          -  Willingness to count carbohydrates and use the insulin pump bolus calculator for all
             boluses during the intervention periods

          -  Willingness to use continuous glucose monitoring consistently during the intervention
             periods

        Exclusion Criteria:

          -  Females of childbearing potential who are pregnant, breast-feeding or intend to become
             pregnant or are not using adequate contraceptive methods

          -  Use of SGLT-2-inhibitors

          -  Use of corticosteroids during or within 30 days prior to the intervention periods

          -  Celiac disease

          -  Inflammatory bowel disease

          -  Macroalbuminuria

          -  Active proliferative retinopathy combined with an HbA1c ≥ 75 mmol/mol (9.0%)

          -  Known or suspected alcohol or drug abuse

          -  Other concomitant medical or psychological condition that according to the
             investigator's assessment makes the patient unsuitable for study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hvidovre University Hospital</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2016</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Copenhagen University Hospital, Hvidovre</investigator_affiliation>
    <investigator_full_name>Signe Schmidt</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

